QUALIFIED PHARMA CONSULTING LTD
Significant control: Dilawaiz Iqbal Afaqui (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Qualified Pharma Consulting Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Qualified Pharma Consulting Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
QUALIFIED PHARMA CONSULTING LTD is an active private limited company (company number 13933849) incorporated on 22 February 2022, registered in Southall. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £4,906, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 43% on the prior period (£3,420).
By net assets it sits in the upper half of 86 comparable companies in Greater London (median £100, upper quartile £35k).
Ownership and control
- Mr Dilawaiz Iqbal Afaqui
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 22 February 20224 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 8 March 2027in 135 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £4,906 | — | — | £348 | — | — | 1 |
| 29 February 2024 | £3,420 | — | — | £802 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £4,906 at 28 February 2025
- Net assets up 10% or more on the prior period+43.5% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 27.05
- Incorporated two to five years agoIncorporated 22 February 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 135 days
- Next accounts duein 35 days
- Accounts period endNet assets £4,906 · micro accounts
- Accounts period endNet assets £3,420 · micro accounts
- Incorporated
Similar companies in Greater London
- INDOCO REMEDIES UK LIMITEDHarrow · inc. Feb 2022
- MIHAAN IMPEX LTDPinner · inc. Feb 2022
- SHA-MA CONSULTANCY LTDWatford · inc. Jan 2022
- PROGRAN HEALTH LIMITEDDartford · inc. May 2022
- BIOVERSE LTDBanstead · inc. Jul 2022
- MINT THERAPEUTICS LTDRuislip, · inc. Sept 2021
All companies incorporated on 22 February 2022 · in Feb 2022.
Reminders for QUALIFIED PHARMA CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.